Want to see SE:CI full AI Analyst Report?
Cell Impact AB (CI) Financial Statements
Cell Impact AB Financial Overview
Cell Impact AB's market cap is currently $29.19M. The company's EPS TTM is $-0.41; its P/E ratio is -0.05; Cell Impact AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.57M | $ 37.33M | $ 47.26M | $ 76.81M | $ 71.35M |
| Gross Profit | $ -121.42M | $ 5.42M | $ 25.45M | $ 36.94M | $ 34.88M |
| Operating Income | $ -124.93M | $ -99.02M | $ -119.49M | $ -103.47M | $ -78.04M |
| EBITDA | $ -55.03M | $ -71.45M | $ -97.72M | $ -86.22M | $ -67.85M |
| Net Income | $ -131.98M | $ -100.43M | $ -121.40M | $ -104.22M | $ -79.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.86M | $ 20.39M | $ 99.89M | $ 164.67M | $ 28.56M |
| Total Assets | $ 163.37M | $ 261.25M | $ 381.93M | $ 401.51M | $ 238.72M |
| Total Debt | $ 32.54M | $ 30.92M | $ 42.75M | $ 44.70M | $ 19.51M |
| Net Debt | $ 21.68M | $ 10.53M | $ -57.15M | $ -119.97M | $ -9.05M |
| Total Liabilities | $ 42.34M | $ 42.16M | $ 78.56M | $ 77.17M | $ 96.10M |
| Stockholders' Equity | $ 121.03M | $ 219.08M | $ 303.37M | $ 324.35M | $ 142.63M |
| Cash Flow | |||||
| Free Cash Flow | $ -47.29M | $ -76.66M | $ -152.75M | $ -174.32M | $ -140.39M |
| Operating Cash Flow | $ -45.36M | $ -62.23M | $ -100.97M | $ -105.93M | $ -86.08M |
| Investing Cash Flow | $ 2.30M | $ -14.43M | $ -51.78M | $ -68.40M | $ -54.32M |
| Financing Cash Flow | $ 33.68M | $ -2.84M | $ 88.09M | $ 310.47M | $ 17.01M |
Currency in SEK
